Amlodipine Besylate/Celecoxib

苯磺酸氨氯地平/塞来昔布

Report date: 2022/03/08 16:45:09

Base Information

Drug NameAmlodipine Besylate/Celecoxib
Drug Alias Name塞来昔布/氨氯地平Celecoxib/Amlodipine苯磺酸氨氯地平和塞来昔布Amlodipine/Celecoxib苯磺酸氨氯地平•塞来昔布 +[17
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated calcium channel blockersCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2Voltage-gated calcium channel
Therapy Area/IndicationsHypertensionOsteoarthritis
Global Approved IndicationsHypertensionOsteoarthritis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2018/05/31
Country/TerritoryUnited StatesUnited Kingdom
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesKitov Pharmaceutical
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHypertensionOsteoarthritis

Other Information

ATC CodeC08CA51
Related LinksN/A